Two out-of-state women have filed separate mass tort claims in a Pennsylvania state
court against the makers of the birth control drug Yaz and its generic equivalent, alleging they sustained various injuries as a result of ingesting the pharmaceutical.
Philadelphia attorneys Sol H. Weiss and Gregory S. Spizer filed the separate claims June 14 at Philadelphia’s Common Pleas Court as short-form complaints in the master Yaz, Yasmin, Ocella Gianvi litigation.
The first complaint was filed on behalf of Mesa, AZ resident Jane Naegle, who will turn 39 at the end of the month.
Naegle took Yasmin from September 2003 until January 2004, Yaz from February 2008 to May 2010, and Gianvi, the generic equivalent of Yaz, from about June 2010 until January 2011.
The plaintiff claims that as a result of taking the drugs, she developed a pulmonary embolism and blood clots early last year.
The second short-form complaint was filed on behalf of Emily Brink, a 22-year-old from South Carolina who claims to have ingested Yaz from October to December 2010 and Gianvi from January 2011 until the spring of that year.
Brink claims she was diagnosed with deep vein thrombus on March 16, 2011, what the plaintiff claims was a direct result of her having taken the prescription birth control drugs.
The defendants named in both suits are Bayer Corp., Berlex Inc., Barr Pharmaceuticals, Teva Pharmaceuticals, along with various subsidiaries for each of the above-listed companies.
Each suit contains counts of fraudulent concealment, strict liability, breach of implied and express warranties, negligent failure to warn, negligent design defect, negligence, negligent misrepresentation, fraud, and violations of state consumer protection laws.
Each plaintiff seeks judgment as set forth in the master litigation.
The case ID numbers are 120601660 and 120601745.